Vicore Pharma Holding AB
STO:VICO
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
6.9665
23.3
|
| Price Target |
|
We'll email you a reminder when the closing price reaches SEK.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Vicore Pharma Holding AB
Vicore Pharma Holding AB
Intangible Assets
Vicore Pharma Holding AB
Intangible Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Intangible Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Vicore Pharma Holding AB
STO:VICO
|
Intangible Assets
kr555k
|
CAGR 3-Years
-80%
|
CAGR 5-Years
-62%
|
CAGR 10-Years
N/A
|
|
|
Biogaia AB
STO:BIOG B
|
Intangible Assets
kr46.2m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
Bonesupport Holding AB
STO:BONEX
|
Intangible Assets
kr14.2m
|
CAGR 3-Years
19%
|
CAGR 5-Years
16%
|
CAGR 10-Years
N/A
|
|
|
Vitrolife AB
STO:VITR
|
Intangible Assets
kr4.3B
|
CAGR 3-Years
152%
|
CAGR 5-Years
63%
|
CAGR 10-Years
74%
|
|
|
Swedish Orphan Biovitrum AB (publ)
STO:SOBI
|
Intangible Assets
kr48.1B
|
CAGR 3-Years
15%
|
CAGR 5-Years
15%
|
CAGR 10-Years
34%
|
|
|
BioArctic AB
STO:BIOA B
|
Intangible Assets
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vicore Pharma Holding AB
Glance View
Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.
See Also
What is Vicore Pharma Holding AB's Intangible Assets?
Intangible Assets
555k
SEK
Based on the financial report for Jun 30, 2024, Vicore Pharma Holding AB's Intangible Assets amounts to 555k SEK.
What is Vicore Pharma Holding AB's Intangible Assets growth rate?
Intangible Assets CAGR 5Y
-62%
Over the last year, the Intangible Assets growth was -99%. The average annual Intangible Assets growth rates for Vicore Pharma Holding AB have been -80% over the past three years , -62% over the past five years .
You don't have any saved screeners yet
